Mandate

Vinge advises Nordic Paper in connection with Strategic Value Partners’ public takeover offer

October 14, 2024

On 11 October 2024, Strategic Value Partners, through Coniferous Bidco AB, announced a public takeover offer to the shareholders in Nordic Paper Holding AB (”Nordic Paper” or the “Company”) to acquire all shares in Nordic Paper.

Nordic Paper is a leading specialty paper producer with its base in Scandinavia, and has been manufacturing top-quality kraft papers and natural greaseproof papers since the 19th century. The share is listed on Nasdaq Stockholm. The total value of the offer amounts to approximately SEK 3,345 million, based on the total number of shares in Nordic Paper. The offer was preceded by a process initiated by the Board of Directors of Nordic Paper to explore the potential interest from third parties for all shares in the Company, after the Company’s current main shareholder, Shanying International Holding Co., Ltd, having announced its intention to sell all or part of its stake in Nordic Paper. Vinge advises Nordic Paper.

Vinge’s team has mainly consisted of David Andersson, Erik Sjöman, Anna Svensson and Michaela Ådén (Capital Markets and Public M&A), Albert Wållgren and Kamyar Najmi (Banking and Finance), Sebastian Örndahl and Martin Hammarskiöld (Anti-trust), Daniel Wendelsson, Dagne Sabockis and Lovisa Lewin (FDI) and Diana Kanold (Transaction Support).

Related

Vinge has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS

Vinge, together with Advokatfirmaet Thommessen, has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS from Å Energi owned Nettpartner AS.
January 19, 2026

Vinge advises KEYTO Group in connection with the acquisition of Smartify

KEYTO Group continues its growth journey by strengthening its offering in Sweden as Smartify Sverige AB joins KEYTO Group.
January 19, 2026

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026